Bibliographic information
GuidelineTherapeutics and COVID-19: living guideline, 16 September 2022.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Originally developed
We suggest not to use remdesivir for patients with critical COVID-19
Recommended against
Conditional
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Therapeutics and COVID-19: living guideline, 13 January 2023.
Year2023
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19: living guideline, 10 November 2023.
Year2023
InstitutionWorld Health Organization
Guideline
Therapeutics and COVID-19: living guideline, August 2025
Year2025
InstitutionWorld Health Organization